Addus HomeCare (NASDAQ:ADUS) Stock Rating Lowered by StockNews.com

Addus HomeCare (NASDAQ:ADUS) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

A number of other research firms have also weighed in on ADUS. KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. JMP Securities started coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price for the company. Finally, Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $133.67.

Addus HomeCare Stock Up 0.4 %

Addus HomeCare stock opened at $133.87 on Thursday. The company has a market capitalization of $2.43 billion, a PE ratio of 30.63, a PEG ratio of 1.63 and a beta of 1.00. The firm’s fifty day moving average is $125.28 and its 200 day moving average is $126.46. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same period last year, the business earned $1.03 EPS. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. Sell-side analysts expect that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock valued at $4,930,750 over the last three months. Insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Institutional investors have recently modified their holdings of the company. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Addus HomeCare in the 3rd quarter worth approximately $1,622,000. Dimensional Fund Advisors LP lifted its stake in Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares during the period. Point72 Asset Management L.P. increased its position in Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the period. JPMorgan Chase & Co. raised its holdings in Addus HomeCare by 10.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after purchasing an additional 16,997 shares in the last quarter. Finally, American Century Companies Inc. lifted its position in shares of Addus HomeCare by 90.6% in the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after purchasing an additional 8,743 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.